|
Volumn 19, Issue 4, 2011, Pages 435-437
|
Unswitch-ABL Drugs Overcome Resistance in Chronic Myeloid Leukemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABELSON KINASE;
BCR ABL PROTEIN;
DCC 2036;
PROTEIN TYROSINE KINASE INHIBITOR;
UNCLASSIFIED DRUG;
ACUTE LYMPHOCYTIC LEUKEMIA;
ANTINEOPLASTIC ACTIVITY;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL (TOPIC);
CONFORMATIONAL TRANSITION;
DRUG DESIGN;
DRUG MECHANISM;
DRUG TARGETING;
ENZYME ACTIVITY;
ENZYME CONFORMATION;
ENZYME INHIBITION;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
|
EID: 79953753585
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccr.2011.03.019 Document Type: Short Survey |
Times cited : (2)
|
References (10)
|